DocuSign (NASDAQ:DOCU) Announces Quarterly Earnings Results

DocuSign (NASDAQ:DOCU - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.86 EPS for the quarter, topping the consensus estimate of $0.84 by $0.02, Briefing.com reports. The business had revenue of $776.25 million for the quarter, compared to the consensus estimate of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The firm's revenue was up 9.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.76 EPS. DocuSign updated its FY 2026 guidance to EPS and its Q1 2026 guidance to EPS.

DocuSign Stock Performance

DocuSign stock traded up $11.06 during midday trading on Friday, reaching $85.76. 11,927,431 shares of the company's stock were exchanged, compared to its average volume of 2,402,407. DocuSign has a 52 week low of $48.70 and a 52 week high of $107.86. The firm has a market cap of $17.33 billion, a price-to-earnings ratio of 17.68, a P/E/G ratio of 6.94 and a beta of 1.02. The stock's 50-day simple moving average is $87.97 and its 200 day simple moving average is $79.37.

Insider Buying and Selling

In related news, CFO Blake Jeffrey Grayson sold 8,000 shares of DocuSign stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $86.90, for a total transaction of $695,200.00. Following the completion of the transaction, the chief financial officer now owns 77,851 shares in the company, valued at approximately $6,765,251.90. This trade represents a 9.32 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Robert Chatwani sold 14,800 shares of DocuSign stock in a transaction dated Wednesday, December 18th. The stock was sold at an average price of $97.76, for a total value of $1,446,848.00. Following the transaction, the insider now owns 73,414 shares of the company's stock, valued at $7,176,952.64. The trade was a 16.78 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 104,422 shares of company stock worth $9,665,394. Company insiders own 1.66% of the company's stock.

Remove Ads

Analysts Set New Price Targets

DOCU has been the subject of a number of research reports. HSBC reiterated a "reduce" rating on shares of DocuSign in a report on Friday, December 6th. Piper Sandler increased their target price on DocuSign from $60.00 to $90.00 and gave the stock a "neutral" rating in a report on Friday, December 6th. Morgan Stanley increased their target price on DocuSign from $62.00 to $97.00 and gave the stock an "equal weight" rating in a report on Friday, December 6th. Robert W. Baird increased their target price on DocuSign from $59.00 to $100.00 and gave the stock a "neutral" rating in a report on Friday, December 6th. Finally, Bank of America lowered their target price on DocuSign from $112.00 to $98.00 and set a "neutral" rating for the company in a report on Friday. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $95.58.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.